
Venkataraman Balasubramanian
Examiner (ID: 3424, Phone: (571)272-0662 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1611 |
| Total Applications | 2999 |
| Issued Applications | 2024 |
| Pending Applications | 254 |
| Abandoned Applications | 724 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13093185
[patent_doc_number] => 10065923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Thickening stabilizer and thickening stabilization composition using same
[patent_app_type] => utility
[patent_app_number] => 15/310146
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5272
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310146 | Thickening stabilizer and thickening stabilization composition using same | Apr 30, 2015 | Issued |
Array
(
[id] => 12102404
[patent_doc_number] => 09859507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Organic electroluminescent compound and organic electroluminescent device comprising the same'
[patent_app_type] => utility
[patent_app_number] => 15/306123
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11813
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306123 | Organic electroluminescent compound and organic electroluminescent device comprising the same | Apr 29, 2015 | Issued |
Array
(
[id] => 10721104
[patent_doc_number] => 20160067251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'ASK 1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/698489
[patent_app_country] => US
[patent_app_date] => 2015-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26274
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14698489
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/698489 | ASK1 inhibiting pyrrolopyrimidine derivatives | Apr 27, 2015 | Issued |
Array
(
[id] => 13013771
[patent_doc_number] => 10029993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Disubstituted 1, 2, 4-triazine compound
[patent_app_type] => utility
[patent_app_number] => 15/305587
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45916
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305587
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305587 | Disubstituted 1, 2, 4-triazine compound | Apr 22, 2015 | Issued |
Array
(
[id] => 10340382
[patent_doc_number] => 20150225387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'INSECTICIDAL TRIAZINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/693998
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58589
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14693998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/693998 | INSECTICIDAL TRIAZINONE DERIVATIVES | Apr 22, 2015 | Abandoned |
Array
(
[id] => 11887980
[patent_doc_number] => 09758533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith'
[patent_app_type] => utility
[patent_app_number] => 14/694744
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 71
[patent_no_of_words] => 17378
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694744
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/694744 | Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith | Apr 22, 2015 | Issued |
Array
(
[id] => 10340333
[patent_doc_number] => 20150225335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'NOVEL HYDROXAMIC ACID DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/692200
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120172
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692200
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692200 | Hydroxamic acid derivative | Apr 20, 2015 | Issued |
Array
(
[id] => 12367113
[patent_doc_number] => 09957239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Process and plant for the synthesis of urea and melamine
[patent_app_type] => utility
[patent_app_number] => 15/126212
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3309
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126212
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/126212 | Process and plant for the synthesis of urea and melamine | Apr 15, 2015 | Issued |
Array
(
[id] => 12408462
[patent_doc_number] => 09969753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => BCR-ABL diploid inhibitor, synthesizing method therefor, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/304438
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9597
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304438 | BCR-ABL diploid inhibitor, synthesizing method therefor, and uses thereof | Apr 15, 2015 | Issued |
Array
(
[id] => 10722332
[patent_doc_number] => 20160068479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'CCR9 INHIBITORS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/687303
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19692
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14687303
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/687303 | CCR9 INHIBITORS AND METHODS OF USE THEREOF | Apr 14, 2015 | Abandoned |
Array
(
[id] => 10324354
[patent_doc_number] => 20150209358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/681974
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60526
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681974
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/681974 | Uracil derivatives as AXL and c-MET kinase inhibitors | Apr 7, 2015 | Issued |
Array
(
[id] => 10083440
[patent_doc_number] => 09120778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Uracil derivatives as AXL and c-MET kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/681981
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60663
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/681981 | Uracil derivatives as AXL and c-MET kinase inhibitors | Apr 7, 2015 | Issued |
Array
(
[id] => 11714851
[patent_doc_number] => 20170183350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/301912
[patent_app_country] => US
[patent_app_date] => 2015-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13242
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301912 | Organic compounds | Apr 2, 2015 | Issued |
Array
(
[id] => 11714842
[patent_doc_number] => 20170183340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'BIARYL KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/300618
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 88757
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300618 | Biaryl kinase inhibitors | Mar 31, 2015 | Issued |
Array
(
[id] => 11589638
[patent_doc_number] => 20170114049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => '2,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/300421
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32274
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300421
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300421 | 2,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES | Mar 30, 2015 | Abandoned |
Array
(
[id] => 11602476
[patent_doc_number] => 20170119776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'CHIRAL 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/300436
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24017
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300436
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300436 | CHIRAL 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND USE THEREOF | Mar 30, 2015 | Abandoned |
Array
(
[id] => 11401632
[patent_doc_number] => 20170022171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => '2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACIDS AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/301392
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63892
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301392
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301392 | 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACIDS AND THEIR USE | Mar 30, 2015 | Abandoned |
Array
(
[id] => 11809065
[patent_doc_number] => 09713623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'Triazine cationic polymers and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/674491
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18306
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14674491
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/674491 | Triazine cationic polymers and methods of use thereof | Mar 30, 2015 | Issued |
Array
(
[id] => 11704515
[patent_doc_number] => 20170173015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/300405
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19325
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/300405 | Prodrugs of HIV reverse transcriptase inhibitors | Mar 26, 2015 | Issued |
Array
(
[id] => 11297773
[patent_doc_number] => 09505768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Compositions and methods for modulating TLR4'
[patent_app_type] => utility
[patent_app_number] => 14/671820
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 36
[patent_no_of_words] => 40284
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671820
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671820 | Compositions and methods for modulating TLR4 | Mar 26, 2015 | Issued |